Women and African Americans are at special risk. This combined vulnerability is an important factor for clinicians treating long-term survivors.
Long-term Cancer Survivorship
Research documents that many cancer survivors experience diminished quality of life (QOL) 1 emanating from physiological sequelae, psychological distress, and social life disruption. 2 However, the existing research pays little attention to cancer as a chronic stressor that may affect QOL over the life course, concentrating instead on the immediate and shortterm effects of cancer, primarily at diagnosis, 3 during treatment, 4 or over the first year after treatment. 5 Bloom 1 suggests that the lack of attention paid to the QOL of long-term cancer survivors is due to the relatively recent improvement in cancer survivor rates. However, Leigh 6 indicates that with the growth in the number of long-term survivors, long-term follow-up care for cancer survivors may become ''a specialty unto itself.'' Unfortunately, as Tomich and Helgeson 7 point out, the studies of long-term survivorship that do exist suffer from methodological weaknesses, including reliance on qualitative data, focus group discussions, and small samples.
The research reported here responds to these criticisms by analyzing quantitative data derived from well-established measures of health and functioning. The data are from a relatively large, randomly selected sample from a major tumor registry data base. Specifically, the purpose of this research is to examine the health QOL of a sample of 321 older-adult (960 years), long-term (Q5 years since the end of active treatment) survivors of breast, colorectal, and prostate cancer. These types of cancer are the 3 most common survivable types of cancer among older adults. 8 More specifically, this research describes the cancer/treatment-related symptoms they continue to experience, the comorbid conditions that they now have, their functional difficulties, and health perceptions. Taken together, the array of measures provides a relatively comprehensive view of the health QOL of these older-adult, long-term cancer survivors. A second purpose of this research is to examine the association between demographic and cancerrelated factors with health QOL for these survivors.
Cancer and Aging
Cancer has special significance for the health of older adults because of the increased likelihood of its occurrence in the older-adult population. Half of all cancers occur in individuals older than 65 years. 9 The incidence rate for all sites triples in the age group of 60 to 79 years, compared with individuals aged 40 to 59 years. 9 Furthermore, the incidence of the most common forms of cancers (lung, colorectal, breast, and prostate) increases dramatically after age 60. 9 Furthermore, for survivors of cancer, the likelihood of a second cancer also increases with advancing age. 10 With the 5-year survival rate for all cancers approaching 60%, there are now an estimated 8 million survivors in the United States, 9 and the majority of these are older than 50 years. Older adults are a particularly vulnerable group of survivors because of the other health problems associated with aging. Havlik et al 11 note that, among older cancer survivors, the presence of comorbidities (the coexistence of various chronic illnesses) has been well documented. However, their effects have not been well examined. This research responds to this limitation in the literature by examining the role that comorbidities play along with cancer-related factors on survivors' health QOL.
Complicating the health QOL of older adults is the fact that they often experience illness symptoms that may be similar to the cancer symptoms that were previously experienced. For the breast cancer survivor, enlarged lymph nodes may signify a recurrence, a new cancer, or a simple infection. For colorectal survivors, digestive problems or abdominal discomfort may have ominous meaning or be the result of a dietary problem. Most prostate survivors recognize the potential for their cancer to spread regionally, thus causing them to perceive problems with urination or elimination as especially threatening. Beyond the fears that symptoms may engender, survivors may be more vulnerable to normative illnesses unrelated to their prior cancer. For these reasons, it is important to document the types of symptoms that older adults experience, their relationship to cancer, and other health outcomes.
Long-term Health Effects of Cancer and Treatment
The long-term health effects of cancer range from those that minimally impact activities of daily living to those that may impair major organ systems. The cancer literature shows that effects such as decreased general functioning and decreased energy level may persist for up to 20 years. 12 For prostate cancer survivors, late effects of radiation include problems in urinating, diarrhea, 13 and rectal complications. 14 Genitourinary morbidity may continue well into the second decade after treatment 15 and represents a lifelong risk. 16 Among breast cancer patients, lymph edema and shoulder morbidity are typical late effects 17 and may progress in prevalence and severity over time. 18 Pinto and Maruyuma identified fatigue as an important long-term effect. 19 Ganz 20 noted that past systemic adjuvant therapies (ie, chemotherapy or hormone therapy) are predictors of poorer physical functioning and pain in long-term survivors. Ramsey et al 21 found that pain and functional limitations persist for colon cancer survivors.
Although prior research clearly has identified the occurrence of specific late effects of cancer, their impact on broader health outcomes such as functional ability and health perceptions has received far less attention. This research, responding to this limitation, examines the association between cancer-related symptoms and health outcomes. Whereas some survivors display ''continuous vulnerability,'' that is, they continue to experience chronic health threats to QOL, other survivors may be ''conditionally'' vulnerable. This latter group may demonstrate relatively good health until a new health crisis or social loss occurs. When this occurs, the cumulative effects of prior cancer-related symptoms combine with the effects of the new comorbidity, which increases the older adult's vulnerability. Therefore, it is important to have an understanding of both the cancer-related and noncancer health issues faced by older adults to assess their overall health QOL.
Research Questions
The literature reviewed above suggests that it is important to document the continuing effects of cancer and its treatment on those who have survived cancer in later life, especially those who are long-term survivors. Therefore, this research will address the following research questions:
1. What are the most prominent comorbidities and continuing cancer/treatment-related symptoms experienced by older-adult, long term survivors? 2. Are there differences in the types of continuing cancer/ treatment-related symptoms by cancer type and sex? 3. What is the association between long-term survivors' demographic characteristics and cancer-related factors and their health and functioning?
n Methods
Data Source
The data analyzed in this research are derived from an ongoing longitudinal project funded by the National Cancer Institute that will ultimately collect 6 waves of data over a 10-year period (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) 
Sample Eligibility/Acquisition
The sample acquisition for the study began in March 1999. Based on the study's inclusion criteria, the tumor registry selected only persons who (1) were 60 years or older, (2) had been treated for breast, colorectal, or prostate cancer, (3) were 5 years or more from diagnosis, and (4) were African American or white. The resulting sampling frame consisted of 2,129 cancer survivors, including 255 (12%) who were African Americans. The study randomly selected from among these individuals to fill the study cells related to race, sex, and cancer type as discussed above. The study also mandated that individuals in the tumor registry who became eligible during sample accrual (having reached age 60 or the 5-year period from active treatment) would be included. These 2 groups, those randomly selected and those achieving eligibility during sample accrual, comprised 799 survivors. Of these, 46 (6%) were ineligible because they reported not meeting one or more of the study's 4 eligibility criteria.
Of the remaining 753 persons, the study was unable to contact 118 (16%), 273 (36%) refused to participate, and 362 (48%) agreed to participate. Of the 362 individuals initially agreeing to participate, 41 (11%) did not complete interviews (the study was unable to contact 11 individuals, 2 died before interviewer contact, 4 were physically or cognitively unable to do the interview, and 24 refused when the interviewer arrived). The remaining 321 (89%) completed the initial wave 1 interview upon which the current research is based.
Interviewing Procedures
The project hired interviewers who were experienced in talking with and obtaining information from older adults with health problems. They participated in a 6-hour training session with the project's coprincipal investigator/project director. Three training modules covered general interviewing techniques, procedures specific to potential risks when interviewing older adults, and question-by-question review of the project's structured survey instrument. Manuals containing these protocols were distributed to interviewers and were updated as the study progressed. After the study was reviewed by an Ireland Cancer Center research review committee and approval obtained from the University Hospitals' institutional review board, letters were sent to prospective respondents from the cancer center's director. Letters included mail-back cards indicating willingness to be contacted by the research project. Names and contact information of interested individuals were passed to research staff who called, explained the project, and obtained verbal consent. Names and contact information of those verbally consenting were forwarded to the interviewing staff. Before beginning the face-to-face interviews, all respondents read and signed written informed consents. Interviews took, on average, 2 hours to complete and were conducted in respondents' homes.
Sample Characteristics
The demographic, health, and cancer-related characteristics of the sample are provided in Tables 1 and 2 . With regard to sex, 59% of the sample was female. Our design strategy of oversampling African Americans resulted in approximately 38% of the sample being from this racial group. With regard to cancer type, the proportion of the total sample with breast cancer was slightly more than 41%, prostate cancer survivors comprised approximately 29% of the sample, and colorectal survivors comprised nearly 30%. The mean age of the survivors was 72.3 years, and the mean age at diagnosis was 61.9 years. The period of time since diagnosis, on average, was 10.4 years.
With regard to the cancer/treatment characteristics, the tumor registry provided information on the stage of the cancer at diagnosis. Most survivors in the sample had in situ (6.5%) or localized cancer (56.7%) at diagnosis. However, nearly 30% had more advanced disease, either regional (27.7%) or distal (1.9%). Focusing next on cancer treatment patterns, the average number of types of treatment received was 1.6. The majority of the sample (43.9 %) received surgery as the only type of treatment, reflecting the localized nature of the disease. The remainder of the sample received combined therapies, including radiation, chemotherapy, and hormone therapy. Approximately 12% received both surgery and radiation therapy, and approximately 10% had surgery and chemotherapy. Only 5% of the sample was treated with a combination of surgery, radiation, and chemotherapy; however, a little more than 15% had other combinations of therapies.
Instrumentation and Measures
The questionnaire used in the in-person interviews covered a range of issues related to the illness experience, such as disease and treatment characteristics, health perceptions, and psychosocial sequelae. 22 The findings reported here focus on the health difficulties, functioning, and overall health perceptions of these older-adult survivors. The specific measures used to operationalize the variables are detailed below.
The Health Conditions Index was adapted from the OARS methodology. 23 It is a sum of the number of health conditions or problems that the survivor reported, from a list of 27 possible conditions such as high blood pressure, allergies, heart trouble, and back and spine problems, and so on. The mean number of health conditions reported was 3.7, with an SD of 2.4. Nearly 50% of the sample reported 4 or more comorbid health conditions.
An index was constructed that reflects respondent's reports of the total number of current symptoms currently being experienced. A list of 22 possible symptoms was provided, including pain, numbness, swelling, weakness, incontinence, nausea, and so on. The average number of symptoms reported was 3.5 (SD, 3.0). The same list of symptoms was used to construct an index of symptoms attributed to cancer/treatment. On average, survivors reported approximately 1 (0.8) continuing symptom attributed to either cancer or its treatment (SD, 1.5). Responses to individual symptoms included in these indices are also used for the descriptive analysis.
This Functional Difficulty Index developed by Nagi 24 assesses the problems survivors have with 11 specific motions or movements, such as standing, lifting or carrying objects, moving limbs, stooping/bending or kneeling, or buttoning a shirt. Responses were scored on a 4-point continuum ranging from no difficulty to unable to perform. The potential range of the index was from 0 to 33 with an actual range of 0 to 25 in this sample. The sample mean was 5.2 with an SD of 5.4, indicating a relatively modest level of impairment. The survivor's perception of effects of the illness on their lives was measured using a 5-item scale, the Illness Impact Scale. This index previously developed by colleagues of the authors has elsewhere been labeled burden of disability. 25 The survivor is asked the extent to which illness has had an impact on their lives. It is not specific to cancer, but rather is a measure of perceived burden based on all their health problems or conditions. Items include ''Do your health conditions prevent you from doing social activities?'' ''Do health problems interfere with your ability to carry out day-to-day activities?'' ''Do you consider yourself disabled?'' ''Do people view you negatively because of your health problems?'' and ''Do you view yourself negatively because of your health problems?'' Responses were scored along a 5-point continuum ranging from ''not at all'' to ''very much.'' This indicator had a potential range of 0 to 20 with an actual range of 5 to 20 in this sample. The mean was 6.9 (SD, 2.9), indicating that, on average, most survivors perceived relatively little burden related to disability. The scale had an " reliability of .76 in this sample.
Respondents were asked a series of questions about their overall health that were used to construct a self-rated health scale. These questions included the following: ''In general, do you consider yourself to be a very healthy, healthy, fairly healthy, sick, or a very sick person?'' ''In general, considering your health over the past year, would you say your health is excellent, good, fair, poor, or very poor?'' ''Compared to other people your age, would you say that your health is much better, better, about the same, worse, or much worse over the past year?'' The potential scores ranged from 5 to 15 and in this sample; the mean was 11.6 with an SD of 2.1 (not shown in table). The " reliability for this scale was .82.
Statistical Analyses
The data reported in this article are descriptive and correlational in nature. The first portion of the analysis addresses research questions 1 and 2. The analysis first presents information on the specific types of comorbid health conditions reported by cancer survivors in this sample. The analysis also provides the number and percentage of the 9 most prominent health conditions reported by survivors, tabulated by cancer type (breast, colorectal, and prostate) and sex. Next, the analysis presents descriptive information on the 16 most common symptoms survivors report as currently being experienced, and the proportion of those symptoms that they attribute to cancer and/or its treatment. P values, based on Pearson 2 2 , are provided to indicate significant differences by cancer type. Next, the analysis provides mean scores of the health outcomes indices and scales (current health conditions, symptoms during cancer, current symptoms, current symptoms attributed to cancer, functional disability, illness impact, and self-rated health).
To address research question 3, correlational data are provided that indicate the degree of association between selected demographic and cancer/treatment factors and the health QOL measures. The coefficients presented are Pearson product-moment correlations. P values are provided, indicating the significance of these coefficients based on Student t (2-tailed) test.
n Results
Comorbidities
The analysis first examines the types of current comorbid health conditions that long-term survivors reported during the initial interview (research question 1). As shown in Table 1 , on average, the sample reported 3.7 conditions with one third of the sample reporting 5 or more conditions. The most common comorbid health condition was high blood pressure reported by 50.8% of the sample (Table 3) . Having allergies, back problems, and heart trouble were each reported by approximately one fourth of the sample. Diabetes was reported by approximately 16%, and joint problems were reported by 14% of the sample. Other conditions that were reported by at least 10% of the sample were skin disorders, urinary tract disorders, stomach or intestinal problems, and osteoporosis. There were significant differences in the comorbid conditions reported by sex. Allergies, back/spine problems, and osteoporosis were reported in greater proportion by breast and female colorectal survivors, compared with male colorectal and prostate cancer survivors. In contrast, urinary tract disorders were reported in greater proportions by male colorectal and prostate cancer survivors than by female survivors.
Current Symptoms
We next examine the illness symptoms currently being experienced by the older-adult, long-term survivors and the proportion of these that survivors attribute to cancer and its treatment. As shown earlier in Table 2 , on average, the survivors in this sample reported less than 1 (0.8) current symptom that they attribute to cancer or its treatment. However, nearly 40% report at least 1 continuing cancer/treatment symptom, and approximately 20% report 2 or more symptoms. Table 4 provides information on the specific symptoms reported by survivors as having occurred during the past year and whether they attribute these symptoms to cancer or cancer treatment. Table 5 provides further detail on symptoms by cancer type (research question 2).
Pain was the most often reported symptom (31.2%), with 21% of survivors who reported this symptom attributing it to cancer or its treatment. This symptom was most common among breast cancer survivors (42.1%) and least common among prostate cancer survivors (19.6%). The next most common current symptom was vision problems (29.9%); however, only 8% of those with this problem attributed it to cancer or its treatment. Numbness was reported by 27.7% of survivors, with 21% of the individuals reporting this symptom attributing it to cancer or its treatment. Numbness was most common among breast cancer survivors (34.6%) and least common among prostate cancer survivors (19.6%).
Of the remaining symptoms reported, the most prominent and most likely to be attributed to cancer was urinary incontinence (24.3% overall, 44.9% attributed to cancer) which was most often reported by prostate cancer survivors (30.4%). Other symptoms included hair loss (21.5% overall, 37.7% attributed to cancer) and diarrhea (18.1% overall, 34.5% attributed to cancer) which was most often reported by colorectal cancer survivors (25%). Bowel incontinence was reported by only a small proportion of the sample (9.3% overall, 11.5% among colorectal cancer survivors, and 12% among prostate cancer survivors). However, of those reporting this symptom, 60% attributed it to cancer. Prostate cancer survivors were most likely to attribute this symptom to cancer when it occurred (81.8%).
Having examined specific conditions and symptoms reported by survivors, the focus of the analysis turns to the more global indicators of health QOL (Table 6 ). In terms of overall patterns, survivors experienced, on average, nearly 4 comorbid health conditions (mean, 3.7) and between 3 and 4 current symptoms (mean, 3.5). As noted earlier, of the current symptoms reported, on average, less than 1 (mean, 0.8) was attributed to cancer. With regard to functioning, this group of survivors in general reported relatively low levels of functional difficulty (mean, 5.2). It is therefore not surprising that they also reported relatively low levels of illness impact (mean, 6.9). All of the above are reflected in their relatively positive self-rated health score (mean, 11.6). Examining the individual items that comprised this index, 22.3% of respondents indicated that, for the past year, they are in excellent health, and 65.6% view their health as better as or much better than others their age (not shown in table) .
Correlational Analysis
The analysis next proceeds to examine the correlates of the health QOL measures used in this research (research question 3). Table 6 provides the intercorrelations of selected demographic and cancer/treatment factors with the health and functioning measures. Most of the coefficients reported range from 0.10 to 0.30, indicating relatively modest levels of correlation. However, given the substantial sample size, even relatively modest levels of association achieve statistical significance. This needs to be kept in mind in interpreting these results. Coefficients achieving significance at the .05 level are discussed in the section that follows (P values of .05, .01, and .001 levels are identified; Table 6 ). Looking first at the correlates of race, being African American is associated with having more current symptoms (r = 0.16), greater functional difficulty (r = 0.23), greater perceived illness impact (r = 0.11), and poorer self-rated health (r = j0.24). However, in this sample, being African American is not significantly associated with having more comorbid health conditions (r = 0.08). Although these coefficients are modest, they consistently point to the poorer health of African-American cancer survivors, compared with whites.
Looking at the correlates of sex, being female is associated with having more comorbid health conditions (r = 0.19), more symptoms during treatment (r = 0.13), more current symptoms (r = 0.26), and a greater perceptions of illness impact (r = 0.11). The strongest health correlate with sex was functional difficulties (r = 0.33), with women reporting substantially more problems in this area. Taken together, these coefficients suggest that female survivors report worse health and functioning than male survivors. However, being female is not associated with more current cancer-related symptoms.
Turning to cancer type, being a breast cancer survivor (compared with the 2 other types of cancer in this research, prostate and colorectal cancer) is associated with having more comorbid health conditions (r = 0.16), more current symptoms (r = 0.22), and more current symptoms associated with cancer (r = 0.11). Being a breast cancer survivor is also associated with more functional difficulties (r = 0.19). Being a colorectal cancer survivor (compared with the other cancer types in this study) was not associated with any of the health outcomes. However, being a prostate cancer survivor was significantly associated with fewer comorbid health conditions (r = j0.14), fewer current symptoms (r = j0.22), and fewer functional difficulties (r = j0.26).
Although this article is about older adults, age differences within the sample are generally not correlated or only weakly correlated with health QOL. As expected, being older is significantly correlated with more functional difficulties (r = 0.19). However, age is associated with fewer symptoms during treatment (r = j0.14) and fewer current symptoms attributed to cancer (r = j0.13).
The analysis focuses next on the association of cancer and treatment characteristics with health and functioning. The number of years since diagnosis is associated with fewer symptoms attributed to cancer (r = j0.11), indicating that the passage of time may have mitigated the symptoms experienced. Duration of survivorship was also significantly associated with more functional difficulties (r = 0.11). Because those who have survived the longest are also the oldest survivors, this correlation is at least in part due to the increase in functional difficulties arising from normal aging.
Survivors who had the most types of treatment reported significantly more symptoms both during treatment (r = 0.21) and current symptoms that they attributed to cancer (r = 0.16). However, having more types of treatment was not significantly associated with poorer functioning, illness impact, or poorer self-rated health. However, one type of treatment, chemotherapy, was associated with more symptoms during treatment (r = 0.31) and more current symptoms caused by cancer (r = 0.16). In this sample, more advanced disease, as indicated by stage at diagnosis, was associated with more total symptoms during treatment (r = 0.19) but was not significantly correlated with any of the indicators of current symptoms, functioning, or self-rated health.
n Discussion An overview of the findings paints an optimistic view of cancer survivorship among older adults, who in this sample are, on average, approximately 70 years old and who are longterm survivors (on average over 10 years). In general, they report good self-rated health, few functional difficulties, and little illness impact. These survivors also report few continuing symptoms related to cancer. However, as older adults, they do experience the chronic conditions typically associated with aging. The analysis provides some insight into the relative role of cancer factors and other broader indicators of their health QOL.
To place these findings in perspective, it is helpful to compare them with a report based on the National Health Interview Survey (NHIS) data. Using these data, Hewitt et al 26 found that older-adult cancer survivors have more chronic conditions, poorer functioning, and generally rate their health poorer than older adults who have not had cancer. In terms of comorbid health conditions, 93% of our survivors reported at least 1 comorbid condition, compared with 42% of cancer survivors and 20% of those without a cancer history in the NHIS. Kurtz et al 27 in a study of older-adult, short-term (e6 weeks) survivors found that 93% had at least 1 comorbid condition, virtually identical to our findings. The average number of comorbid conditions reported by their respondents was 2.7, approximately 1 condition less on average than we found in our research.
Similarly, in another study of short-term survivors, Ogle et al 28 found that nearly 70% had at least one comorbid condition and, on average, more than 2 conditions. These comparisons suggest that survivors in our study experience as many or more chronic health problems than the above groups of cancer survivors, and more than older adults in general. This may be due at least in part to the large proportion of women and oversampling of African Americans in this sample, 2 groups who typically report more chronic health problems. This research replicates previous survivorship research that found women have the highest number of comorbidities.
However, in spite of these comorbidities, approximately three fourths of our sample rated their health as either excellent or good. This compares closely with the NHIS data where approximately 65% of older-adult cancer survivors rate their health as good or better (excellent, very good, or good) and 75% of older adults without a history of cancer who rate their health similarly. Although the NHIS data and the results of our research are not strictly comparable (eg, possible differences in age structure, cancer type, and/or duration of survivorship), both studies suggest that cancer survivors report being in relatively good health in spite of comorbidities.
In terms of cancer-related symptoms, the mean number of continuing symptoms reported by survivors in this research is relatively low. Unfortunately, neither the NHIS data nor other survivorship studies provide comparable data on symptoms. However, this relatively low average level of reported symptoms obscures the potential needs of a considerable proportion of survivors. Nearly 40% of survivors in this research continue to have at least 1 symptom, and 10% have 3 or more continuing symptom. Looking at symptom reports by the type of cancer, the data show that breast cancer survivors experience continuing pain, swelling, numbness, and weakness. This replicates findings by Vecht 12 with regard to continuing weakness. Prostate survivors are more likely to report urinary and bowel incontinence. This is consistent with the findings of Perez et al, 13 Gardener et al, 15 and Fitch et al, 29 Furthermore, colorectal cancer survivors are more likely to report diarrhea, which reinforces the findings of Ramsey et al. 21 These continuing symptoms may represent a threat to health QOL and need to be recognized by primary care physicians, nurses, and other healthcare practitioners who treat olderadult survivors.
In general, the level of association between the demographic and cancer-related factors and the health QOL outcomes are quite modest, although statistically significant in many cases. As a result, caution should be used in their interpretation. However, the correlational data do reinforce the descriptive data that indicate that women and African-American survivors are more likely to have poorer functional difficulties. Yet, the correlations also suggest that this is not necessarily linked to cancer because neither sex nor race is significantly associated with more continuing symptoms attributed to cancer or its treatment.
Compared to the other types of cancer in this study, breast cancer was associated with more current symptoms, more symptoms attributed to cancer, and more functional difficulty.
A portion of this relationship between breast cancer and both overall symptoms and functional difficulties is, no doubt, due to the effects of sex and its link to comorbidities. However, the modest but statistically significant association with current symptoms attributed to cancer/treatment may speak directly to the vulnerability of long-term breast cancer survivors, compared with colorectal and prostate cancer survivors.
Cancer treatment factors were also shown to be statistically significant, if modest correlates of health and functioning. Having had more types of treatment and chemotherapy were both associated with more symptoms during treatment and more current symptoms attributed to cancer. Primary care physicians, geriatricians, and nurses working in these setting may be unaware of the cancer and treatment history of their older-adult patients, especially if that treatment ended decades previously. Specifically, these healthcare providers need to be aware that for a small but important proportion of survivors, continuing symptoms may interact with or exacerbate symptoms that are related to other, more recent health problems. They also need to be aware that the symptoms that they report may have special significance because they are cancer survivors, raising fears of a recurrence or another new cancer.
Taken together, findings suggest that older-adult, longterm survivors experience more health problems than older adults in general. In addition, a small subgroup of survivors continues to have long-term effects of cancer or its treatment which, combined with comorbidities, creates additional risks to their QOL. Women and minorities are particularly vulnerable, not only because of their cancer survivorship, but also because of their other health and functional problems. It is therefore important for clinicians who work with older-adult survivors to be aware of the additional vulnerability that cancer survivorship may confer on these individuals. Educational opportunities relevant to cancer are presented in this feature. Nurses and other health professionals are invited to submit notices of symposia, workshops, and continuing education offerings to: Carol Reed Ash, Editor, Cancer Nursing, University of Florida, College of Nursing, P.O. Box 100187, Gainesville, FL 32611. Academic programs leading to advanced degrees in cancer nursing will be listed at the request of the sponsoring agency or institution. Selections of items for review will be based on their relevance to cancer care and the availability of space. Items must be submitted at least four months prior to the program date.
